Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 6 of 6 entries
Sorted by: Best Match Show Resources per page
Cell Attachment and Spreading on Carbon Nanotubes Is Facilitated by Integrin Binding.

Frontiers in bioengineering and biotechnology

Imaninezhad M, Schober J, Griggs D, Ruminski P, Kuljanishvili I, Zustiak SP.
PMID: 30320079
Front Bioeng Biotechnol. 2018 Sep 24;6:129. doi: 10.3389/fbioe.2018.00129. eCollection 2018.

Owing to their exceptional physical, chemical, and mechanical properties, carbon nanotubes (CNTs) have been extensively studied for their effect on cellular behaviors. However, little is known about the process by which cells attach and spread on CNTs and the...

Cite
Imaninezhad M, Schober J, Griggs D, et al. Cell Attachment and Spreading on Carbon Nanotubes Is Facilitated by Integrin Binding. Front Bioeng Biotechnol. 2018;6:129doi: 10.3389/fbioe.2018.00129.
Imaninezhad, M., Schober, J., Griggs, D., Ruminski, P., Kuljanishvili, I., & Zustiak, S. P. (2018). Cell Attachment and Spreading on Carbon Nanotubes Is Facilitated by Integrin Binding. Frontiers in bioengineering and biotechnology, 6129. https://doi.org/10.3389/fbioe.2018.00129
Imaninezhad, Mozhdeh, et al. "Cell Attachment and Spreading on Carbon Nanotubes Is Facilitated by Integrin Binding." Frontiers in bioengineering and biotechnology vol. 6 (2018): 129. doi: https://doi.org/10.3389/fbioe.2018.00129
Imaninezhad M, Schober J, Griggs D, Ruminski P, Kuljanishvili I, Zustiak SP. Cell Attachment and Spreading on Carbon Nanotubes Is Facilitated by Integrin Binding. Front Bioeng Biotechnol. 2018 Sep 24;6:129. doi: 10.3389/fbioe.2018.00129. eCollection 2018. PMID: 30320079; PMCID: PMC6165858.
Copy Download .nbib Format: NLM
Expanding the mutational landscape and clinical phenotype of the YIF1B related brain disorder.

Brain : a journal of neurology

Medico Salsench E, Maroofian R, Deng R, Lanko K, Nikoncuk A, Pérez B, Sánchez-Lijarcio O, Ibáñez-Mico S, Wojcik A, Vargas M, Abbas Al-Sannaa N, Girgis MY, Silveira TRD, Bauer P, Schroeder A, Fong CT, Begtrup A, Babaei M, Toosi MB, Ashrafzadeh F, Imannezhad S, Doosti M, Ahangari N, Najarzadeh Torbati P, Ghayoor Karimiani E, Murphy D, Cali E, Kaya IH, AlMuhaizea M, Colak D, Cardona-Londoño KJ, Arold ST, Houlden H, Bertoli-Avella A, Kaya N, Barakat TS.
PMID: 34373908
Brain. 2021 Nov 29;144(10):e85. doi: 10.1093/brain/awab297.

No abstract available.

Cite
Medico Salsench E, Maroofian R, Deng R, et al. Expanding the mutational landscape and clinical phenotype of the YIF1B related brain disorder. Brain. 2021;144(10):e85doi: 10.1093/brain/awab297.
Medico Salsench, E., Maroofian, R., Deng, R., Lanko, K., Nikoncuk, A., Pérez, B., Sánchez-Lijarcio, O., Ibáñez-Mico, S., Wojcik, A., Vargas, M., Abbas Al-Sannaa, N., Girgis, M. Y., Silveira, T. R. D., Bauer, P., Schroeder, A., Fong, C. T., Begtrup, A., Babaei, M., Toosi, M. B., Ashrafzadeh, F., Imannezhad, S., Doosti, M., Ahangari, N., Najarzadeh Torbati, P., Ghayoor Karimiani, E., Murphy, D., Cali, E., Kaya, I. H., AlMuhaizea, M., Colak, D., Cardona-Londoño, K. J., Arold, S. T., Houlden, H., Bertoli-Avella, A., Kaya, N., & Barakat, T. S. (2021). Expanding the mutational landscape and clinical phenotype of the YIF1B related brain disorder. Brain : a journal of neurology, 144(10), e85. https://doi.org/10.1093/brain/awab297
Medico Salsench, Eva, et al. "Expanding the mutational landscape and clinical phenotype of the YIF1B related brain disorder." Brain : a journal of neurology vol. 144,10 (2021): e85. doi: https://doi.org/10.1093/brain/awab297
Medico Salsench E, Maroofian R, Deng R, Lanko K, Nikoncuk A, Pérez B, Sánchez-Lijarcio O, Ibáñez-Mico S, Wojcik A, Vargas M, Abbas Al-Sannaa N, Girgis MY, Silveira TRD, Bauer P, Schroeder A, Fong CT, Begtrup A, Babaei M, Toosi MB, Ashrafzadeh F, Imannezhad S, Doosti M, Ahangari N, Najarzadeh Torbati P, Ghayoor Karimiani E, Murphy D, Cali E, Kaya IH, AlMuhaizea M, Colak D, Cardona-Londoño KJ, Arold ST, Houlden H, Bertoli-Avella A, Kaya N, Barakat TS. Expanding the mutational landscape and clinical phenotype of the YIF1B related brain disorder. Brain. 2021 Nov 29;144(10):e85. doi: 10.1093/brain/awab297. PMID: 34373908; PMCID: PMC8634087.
Copy Download .nbib Format: NLM
Buckling of a linear chain of hard spheres in a harmonic confining potential: Numerical and analytical results for low and high compression.

Physical review. E

Hutzler S, Mughal A, Ryan-Purcell J, Irannezhad A, Weaire D.
PMID: 32942376
Phys Rev E. 2020 Aug;102(2):022905. doi: 10.1103/PhysRevE.102.022905.

We extend a previous analysis of the buckling properties of a linear chain of hard spheres between hard walls under transverse harmonic confinement. Two regimes are distinguished-low compression, for which the entire chain buckles, and higher compression, for which...

Cite
Hutzler S, Mughal A, Ryan-Purcell J, et al. Buckling of a linear chain of hard spheres in a harmonic confining potential: Numerical and analytical results for low and high compression. Phys Rev E. 2020;102(2):022905doi: 10.1103/PhysRevE.102.022905.
Hutzler, S., Mughal, A., Ryan-Purcell, J., Irannezhad, A., & Weaire, D. (2020). Buckling of a linear chain of hard spheres in a harmonic confining potential: Numerical and analytical results for low and high compression. Physical review. E, 102(2), 022905. https://doi.org/10.1103/PhysRevE.102.022905
Hutzler, Stefan, et al. "Buckling of a linear chain of hard spheres in a harmonic confining potential: Numerical and analytical results for low and high compression." Physical review. E vol. 102,2 (2020): 022905. doi: https://doi.org/10.1103/PhysRevE.102.022905
Hutzler S, Mughal A, Ryan-Purcell J, Irannezhad A, Weaire D. Buckling of a linear chain of hard spheres in a harmonic confining potential: Numerical and analytical results for low and high compression. Phys Rev E. 2020 Aug;102(2):022905. doi: 10.1103/PhysRevE.102.022905. PMID: 32942376.
Copy Download .nbib Format: NLM
Evaluation of Synergistic Interactions Between Cell-Free Supernatant of Lactobacillus Strains and Amikacin and Genetamicin Against Pseudomonas aeruginosa.

Jundishapur journal of microbiology

Aminnezhad S, Kermanshahi RK, Ranjbar R.
PMID: 26034539
Jundishapur J Microbiol. 2015 Apr 18;8(4):e16592. doi: 10.5812/jjm.8(4)2015.16592. eCollection 2015 Apr.

BACKGROUND: The indiscriminate use of antibiotics in the treatment of infectious diseases can increase the development of antibiotic resistance. Therefore, there is a big demand for new sources of antimicrobial agents and alternative treatments for reduction of antibiotic dosage...

Cite
Aminnezhad S, Kermanshahi RK, Ranjbar R. Evaluation of Synergistic Interactions Between Cell-Free Supernatant of Lactobacillus Strains and Amikacin and Genetamicin Against Pseudomonas aeruginosa. Jundishapur J Microbiol. 2015;8(4):e16592doi: 10.5812/jjm.8(4)2015.16592.
Aminnezhad, S., Kermanshahi, R. K., & Ranjbar, R. (2015). Evaluation of Synergistic Interactions Between Cell-Free Supernatant of Lactobacillus Strains and Amikacin and Genetamicin Against Pseudomonas aeruginosa. Jundishapur journal of microbiology, 8(4), e16592. https://doi.org/10.5812/jjm.8(4)2015.16592
Aminnezhad, Sargol, et al. "Evaluation of Synergistic Interactions Between Cell-Free Supernatant of Lactobacillus Strains and Amikacin and Genetamicin Against Pseudomonas aeruginosa." Jundishapur journal of microbiology vol. 8,4 (2015): e16592. doi: https://doi.org/10.5812/jjm.8(4)2015.16592
Aminnezhad S, Kermanshahi RK, Ranjbar R. Evaluation of Synergistic Interactions Between Cell-Free Supernatant of Lactobacillus Strains and Amikacin and Genetamicin Against Pseudomonas aeruginosa. Jundishapur J Microbiol. 2015 Apr 18;8(4):e16592. doi: 10.5812/jjm.8(4)2015.16592. eCollection 2015 Apr. PMID: 26034539; PMCID: PMC4449849.
Copy Download .nbib Format: NLM
Clinico-radiological features, molecular spectrum, and identification of prognostic factors in developmental and epileptic encephalopathy due to inosine triphosphate pyrophosphatase (ITPase) deficiency.

Human mutation

Scala M, Wortmann SB, Kaya N, Stellingwerff MD, Pistorio A, Glamuzina E, van Karnebeek CD, Skrypnyk C, Iwanicka-Pronicka K, Piekutowska-Abramczuk D, Ciara E, Tort F, Sheidley B, Poduri A, Jayakar P, Jayakar A, Upadia J, Walano N, Haack TB, Prokisch H, Aldhalaan H, Karimiani EG, Yildiz Y, Ceylan AC, Santiago-Sim T, Dameron A, Yang H, Toosi MB, Ashrafzadeh F, Akhondian J, Imannezhad S, Mirzadeh HS, Maqbool S, Farid A, Al-Muhaizea MA, Alshwameen MO, Aldowsari L, Alsagob M, Alyousef A, AlMass R, AlHargan A, Alwadei AH, AlRasheed MM, Colak D, Alqudairy H, Khan S, Lines MA, García Cazorla MÁ, Ribes A, Morava E, Bibi F, Haider S, Ferla MP, Taylor JC, Alsaif HS, Firdous A, Hashem M, Shashkin C, Koneev K, Kaiyrzhanov R, Efthymiou S, Genomics QS, Schmitt-Mechelke T, Ziegler A, Issa MY, Elbendary HM, Striano P, Alkuraya FS, Zaki MS, Gleeson JG, Barakat TS, Bierau J, van der Knaap MS, Maroofian R, Houlden H.
PMID: 34989426
Hum Mutat. 2022 Jan 06; doi: 10.1002/humu.24326. Epub 2022 Jan 06.

Developmental and epileptic encephalopathy 35 (DEE 35) is a severe neurological condition caused by biallelic variants in ITPA, encoding inosine triphosphate pyrophosphatase, an essential enzyme in purine metabolism. We delineate the genotypic and phenotypic spectrum of DEE 35, analysing...

Cite
Scala M, Wortmann SB, Kaya N, et al. Clinico-radiological features, molecular spectrum, and identification of prognostic factors in developmental and epileptic encephalopathy due to inosine triphosphate pyrophosphatase (ITPase) deficiency. Hum Mutat. 2022;doi: 10.1002/humu.24326.
Scala, M., Wortmann, S. B., Kaya, N., Stellingwerff, M. D., Pistorio, A., Glamuzina, E., van Karnebeek, C. D., Skrypnyk, C., Iwanicka-Pronicka, K., Piekutowska-Abramczuk, D., Ciara, E., Tort, F., Sheidley, B., Poduri, A., Jayakar, P., Jayakar, A., Upadia, J., Walano, N., Haack, T. B., Prokisch, H., Aldhalaan, H., Karimiani, E. G., Yildiz, Y., Ceylan, A. C., Santiago-Sim, T., Dameron, A., Yang, H., Toosi, M. B., Ashrafzadeh, F., Akhondian, J., Imannezhad, S., Mirzadeh, H. S., Maqbool, S., Farid, A., Al-Muhaizea, M. A., Alshwameen, M. O., Aldowsari, L., Alsagob, M., Alyousef, A., AlMass, R., AlHargan, A., Alwadei, A. H., AlRasheed, M. M., Colak, D., Alqudairy, H., Khan, S., Lines, M. A., García Cazorla, M. �. �., Ribes, A., Morava, E., Bibi, F., Haider, S., Ferla, M. P., Taylor, J. C., Alsaif, H. S., Firdous, A., Hashem, M., Shashkin, C., Koneev, K., Kaiyrzhanov, R., Efthymiou, S., Genomics, Q. S., Schmitt-Mechelke, T., Ziegler, A., Issa, M. Y., Elbendary, H. M., Striano, P., Alkuraya, F. S., Zaki, M. S., Gleeson, J. G., Barakat, T. S., Bierau, J., van der Knaap, M. S., Maroofian, R., & Houlden, H. (2022). Clinico-radiological features, molecular spectrum, and identification of prognostic factors in developmental and epileptic encephalopathy due to inosine triphosphate pyrophosphatase (ITPase) deficiency. Human mutation, . https://doi.org/10.1002/humu.24326
Scala, Marcello, et al. "Clinico-radiological features, molecular spectrum, and identification of prognostic factors in developmental and epileptic encephalopathy due to inosine triphosphate pyrophosphatase (ITPase) deficiency." Human mutation vol. (2022). doi: https://doi.org/10.1002/humu.24326
Scala M, Wortmann SB, Kaya N, Stellingwerff MD, Pistorio A, Glamuzina E, van Karnebeek CD, Skrypnyk C, Iwanicka-Pronicka K, Piekutowska-Abramczuk D, Ciara E, Tort F, Sheidley B, Poduri A, Jayakar P, Jayakar A, Upadia J, Walano N, Haack TB, Prokisch H, Aldhalaan H, Karimiani EG, Yildiz Y, Ceylan AC, Santiago-Sim T, Dameron A, Yang H, Toosi MB, Ashrafzadeh F, Akhondian J, Imannezhad S, Mirzadeh HS, Maqbool S, Farid A, Al-Muhaizea MA, Alshwameen MO, Aldowsari L, Alsagob M, Alyousef A, AlMass R, AlHargan A, Alwadei AH, AlRasheed MM, Colak D, Alqudairy H, Khan S, Lines MA, García Cazorla MÁ, Ribes A, Morava E, Bibi F, Haider S, Ferla MP, Taylor JC, Alsaif HS, Firdous A, Hashem M, Shashkin C, Koneev K, Kaiyrzhanov R, Efthymiou S, Genomics QS, Schmitt-Mechelke T, Ziegler A, Issa MY, Elbendary HM, Striano P, Alkuraya FS, Zaki MS, Gleeson JG, Barakat TS, Bierau J, van der Knaap MS, Maroofian R, Houlden H. Clinico-radiological features, molecular spectrum, and identification of prognostic factors in developmental and epileptic encephalopathy due to inosine triphosphate pyrophosphatase (ITPase) deficiency. Hum Mutat. 2022 Jan 06; doi: 10.1002/humu.24326. Epub 2022 Jan 06. PMID: 34989426.
Copy Download .nbib Format: NLM
Clinico-radiological features, molecular spectrum, and identification of prognostic factors in developmental and epileptic encephalopathy due to inosine triphosphate pyrophosphatase (ITPase) deficiency.

Human mutation

Scala M, Wortmann SB, Kaya N, Stellingwerff MD, Pistorio A, Glamuzina E, van Karnebeek CD, Skrypnyk C, Iwanicka-Pronicka K, Piekutowska-Abramczuk D, Ciara E, Tort F, Sheidley B, Poduri A, Jayakar P, Jayakar A, Upadia J, Walano N, Haack TB, Prokisch H, Aldhalaan H, Karimiani EG, Yildiz Y, Ceylan AC, Santiago-Sim T, Dameron A, Yang H, Toosi MB, Ashrafzadeh F, Akhondian J, Imannezhad S, Mirzadeh HS, Maqbool S, Farid A, Al-Muhaizea MA, Alshwameen MO, Aldowsari L, Alsagob M, Alyousef A, AlMass R, AlHargan A, Alwadei AH, AlRasheed MM, Colak D, Alqudairy H, Khan S, Lines MA, García Cazorla MÁ, Ribes A, Morava E, Bibi F, Haider S, Ferla MP, Taylor JC, Alsaif HS, Firdous A, Hashem M, Shashkin C, Koneev K, Kaiyrzhanov R, Efthymiou S, Genomics QS, Schmitt-Mechelke T, Ziegler A, Issa MY, Elbendary HM, Striano P, Alkuraya FS, Zaki MS, Gleeson JG, Barakat TS, Bierau J, van der Knaap MS, Maroofian R, Houlden H.
PMID: 34989426
Hum Mutat. 2022 Jan 06; doi: 10.1002/humu.24326. Epub 2022 Jan 06.

Developmental and epileptic encephalopathy 35 (DEE 35) is a severe neurological condition caused by biallelic variants in ITPA, encoding inosine triphosphate pyrophosphatase, an essential enzyme in purine metabolism. We delineate the genotypic and phenotypic spectrum of DEE 35, analyzing...

Cite
Scala M, Wortmann SB, Kaya N, et al. Clinico-radiological features, molecular spectrum, and identification of prognostic factors in developmental and epileptic encephalopathy due to inosine triphosphate pyrophosphatase (ITPase) deficiency. Hum Mutat. 2022;doi: 10.1002/humu.24326.
Scala, M., Wortmann, S. B., Kaya, N., Stellingwerff, M. D., Pistorio, A., Glamuzina, E., van Karnebeek, C. D., Skrypnyk, C., Iwanicka-Pronicka, K., Piekutowska-Abramczuk, D., Ciara, E., Tort, F., Sheidley, B., Poduri, A., Jayakar, P., Jayakar, A., Upadia, J., Walano, N., Haack, T. B., Prokisch, H., Aldhalaan, H., Karimiani, E. G., Yildiz, Y., Ceylan, A. C., Santiago-Sim, T., Dameron, A., Yang, H., Toosi, M. B., Ashrafzadeh, F., Akhondian, J., Imannezhad, S., Mirzadeh, H. S., Maqbool, S., Farid, A., Al-Muhaizea, M. A., Alshwameen, M. O., Aldowsari, L., Alsagob, M., Alyousef, A., AlMass, R., AlHargan, A., Alwadei, A. H., AlRasheed, M. M., Colak, D., Alqudairy, H., Khan, S., Lines, M. A., García Cazorla, M. �. �., Ribes, A., Morava, E., Bibi, F., Haider, S., Ferla, M. P., Taylor, J. C., Alsaif, H. S., Firdous, A., Hashem, M., Shashkin, C., Koneev, K., Kaiyrzhanov, R., Efthymiou, S., Genomics, Q. S., Schmitt-Mechelke, T., Ziegler, A., Issa, M. Y., Elbendary, H. M., Striano, P., Alkuraya, F. S., Zaki, M. S., Gleeson, J. G., Barakat, T. S., Bierau, J., van der Knaap, M. S., Maroofian, R., & Houlden, H. (2022). Clinico-radiological features, molecular spectrum, and identification of prognostic factors in developmental and epileptic encephalopathy due to inosine triphosphate pyrophosphatase (ITPase) deficiency. Human mutation, . https://doi.org/10.1002/humu.24326
Scala, Marcello, et al. "Clinico-radiological features, molecular spectrum, and identification of prognostic factors in developmental and epileptic encephalopathy due to inosine triphosphate pyrophosphatase (ITPase) deficiency." Human mutation vol. (2022). doi: https://doi.org/10.1002/humu.24326
Scala M, Wortmann SB, Kaya N, Stellingwerff MD, Pistorio A, Glamuzina E, van Karnebeek CD, Skrypnyk C, Iwanicka-Pronicka K, Piekutowska-Abramczuk D, Ciara E, Tort F, Sheidley B, Poduri A, Jayakar P, Jayakar A, Upadia J, Walano N, Haack TB, Prokisch H, Aldhalaan H, Karimiani EG, Yildiz Y, Ceylan AC, Santiago-Sim T, Dameron A, Yang H, Toosi MB, Ashrafzadeh F, Akhondian J, Imannezhad S, Mirzadeh HS, Maqbool S, Farid A, Al-Muhaizea MA, Alshwameen MO, Aldowsari L, Alsagob M, Alyousef A, AlMass R, AlHargan A, Alwadei AH, AlRasheed MM, Colak D, Alqudairy H, Khan S, Lines MA, García Cazorla MÁ, Ribes A, Morava E, Bibi F, Haider S, Ferla MP, Taylor JC, Alsaif HS, Firdous A, Hashem M, Shashkin C, Koneev K, Kaiyrzhanov R, Efthymiou S, Genomics QS, Schmitt-Mechelke T, Ziegler A, Issa MY, Elbendary HM, Striano P, Alkuraya FS, Zaki MS, Gleeson JG, Barakat TS, Bierau J, van der Knaap MS, Maroofian R, Houlden H. Clinico-radiological features, molecular spectrum, and identification of prognostic factors in developmental and epileptic encephalopathy due to inosine triphosphate pyrophosphatase (ITPase) deficiency. Hum Mutat. 2022 Jan 06; doi: 10.1002/humu.24326. Epub 2022 Jan 06. PMID: 34989426.
Copy Download .nbib Format: NLM
Showing 1 to 6 of 6 entries